Jevtana is a prescription medication used to treat prostate cancer in adults. Jevtana belongs to a group of drugs called microtubule inhibitors, which slow and stop the growth of cancer cells.
This medication comes in an injectable form to be given directly into the vein (IV) by a healthcare provider once every 3 weeks.
Common side effects of Jevtana include low red blood cell count, low blood platelet count, and tiredness. Do not drink grapefruit juice while taking Jevtana.
WARNING
Neutropenic deaths have been reported. In order to monitor the occurrence of neutropenia, frequent blood cell counts should be performed on all patients receiving Jevtana. This medication should not be given to patients with neutrophil counts of ≤1,500 cells/mm3.
Severe hypersensitivity reactions can occur and may include generalized rash/erythema, hypotension and bronchospasm. Severe hypersensitivity reactions require immediate discontinuation of the Jevtana infusion and administration of appropriate therapy. Patients should receive premedication. Jevtana must not be given to patients who have a history of severe hypersensitivity reactions to Jevtana or to other drugs formulated with polysorbate 80.